Development of high sustained IgG antibody titers and corresponding clinical decline in an adolescent with atypical infantile Pompe disease after 11+ years on enzyme replacement therapy with alglucosidase alfa
Publication
, Conference
Kim, KH; Vucko, E; Desai, AK; Kishnani, P; Burton, BK
Published in: Molecular Genetics and Metabolism
February 2020
Duke Scholars
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2020
Volume
129
Issue
2
Start / End Page
S89 / S89
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kim, K. H., Vucko, E., Desai, A. K., Kishnani, P., & Burton, B. K. (2020). Development of high sustained IgG antibody titers and corresponding clinical decline in an adolescent with atypical infantile Pompe disease after 11+ years on enzyme replacement therapy with alglucosidase alfa. In Molecular Genetics and Metabolism (Vol. 129, pp. S89–S89). Elsevier BV. https://doi.org/10.1016/j.ymgme.2019.11.221
Kim, Katherine H., Erika Vucko, Ankit K. Desai, Priya Kishnani, and Barbara K. Burton. “Development of high sustained IgG antibody titers and corresponding clinical decline in an adolescent with atypical infantile Pompe disease after 11+ years on enzyme replacement therapy with alglucosidase alfa.” In Molecular Genetics and Metabolism, 129:S89–S89. Elsevier BV, 2020. https://doi.org/10.1016/j.ymgme.2019.11.221.
Kim KH, Vucko E, Desai AK, Kishnani P, Burton BK. Development of high sustained IgG antibody titers and corresponding clinical decline in an adolescent with atypical infantile Pompe disease after 11+ years on enzyme replacement therapy with alglucosidase alfa. In: Molecular Genetics and Metabolism. Elsevier BV; 2020. p. S89–S89.
Kim, Katherine H., et al. “Development of high sustained IgG antibody titers and corresponding clinical decline in an adolescent with atypical infantile Pompe disease after 11+ years on enzyme replacement therapy with alglucosidase alfa.” Molecular Genetics and Metabolism, vol. 129, no. 2, Elsevier BV, 2020, pp. S89–S89. Crossref, doi:10.1016/j.ymgme.2019.11.221.
Kim KH, Vucko E, Desai AK, Kishnani P, Burton BK. Development of high sustained IgG antibody titers and corresponding clinical decline in an adolescent with atypical infantile Pompe disease after 11+ years on enzyme replacement therapy with alglucosidase alfa. Molecular Genetics and Metabolism. Elsevier BV; 2020. p. S89–S89.
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2020
Volume
129
Issue
2
Start / End Page
S89 / S89
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences